PortfoliosLab logoPortfoliosLab logo
WST vs. FRT
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

WST vs. FRT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in West Pharmaceutical Services, Inc. (WST) and Federal Realty Investment Trust (FRT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

WST vs. FRT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
WST
West Pharmaceutical Services, Inc.
-8.82%-15.73%-6.75%49.97%-49.70%65.88%89.05%54.13%-0.08%17.02%
FRT
Federal Realty Investment Trust
6.56%-5.91%12.07%6.55%-22.66%65.97%-30.66%12.51%-8.10%-3.59%

Fundamentals

Market Cap

WST:

$18.22B

FRT:

$9.13B

EPS

WST:

$6.79

FRT:

$4.77

PE Ratio

WST:

36.93

FRT:

22.27

PS Ratio

WST:

5.93

FRT:

7.15

PB Ratio

WST:

5.74

FRT:

2.81

Total Revenue (TTM)

WST:

$3.07B

FRT:

$1.28B

Gross Profit (TTM)

WST:

$1.10B

FRT:

$860.70M

EBITDA (TTM)

WST:

$723.60M

FRT:

$970.04M

Returns By Period

In the year-to-date period, WST achieves a -8.82% return, which is significantly lower than FRT's 6.56% return. Over the past 10 years, WST has outperformed FRT with an annualized return of 13.95%, while FRT has yielded a comparatively lower -0.20% annualized return.


WST

1D
2.24%
1M
-1.45%
YTD
-8.82%
6M
-4.29%
1Y
12.35%
3Y*
-9.99%
5Y*
-2.27%
10Y*
13.95%

FRT

1D
1.68%
1M
-2.35%
YTD
6.56%
6M
7.22%
1Y
13.63%
3Y*
6.60%
5Y*
4.50%
10Y*
-0.20%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WST vs. FRT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WST
WST Risk / Return Rank: 5353
Overall Rank
WST Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
WST Sortino Ratio Rank: 5252
Sortino Ratio Rank
WST Omega Ratio Rank: 5050
Omega Ratio Rank
WST Calmar Ratio Rank: 5555
Calmar Ratio Rank
WST Martin Ratio Rank: 5555
Martin Ratio Rank

FRT
FRT Risk / Return Rank: 6363
Overall Rank
FRT Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
FRT Sortino Ratio Rank: 5757
Sortino Ratio Rank
FRT Omega Ratio Rank: 5656
Omega Ratio Rank
FRT Calmar Ratio Rank: 6363
Calmar Ratio Rank
FRT Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WST vs. FRT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and Federal Realty Investment Trust (FRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WSTFRTDifference

Sharpe ratio

Return per unit of total volatility

0.30

0.63

-0.33

Sortino ratio

Return per unit of downside risk

0.83

1.04

-0.21

Omega ratio

Gain probability vs. loss probability

1.10

1.13

-0.03

Calmar ratio

Return relative to maximum drawdown

0.53

0.94

-0.40

Martin ratio

Return relative to average drawdown

1.10

3.71

-2.62

WST vs. FRT - Sharpe Ratio Comparison

The current WST Sharpe Ratio is 0.30, which is lower than the FRT Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of WST and FRT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


WSTFRTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.30

0.63

-0.33

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.06

0.19

-0.25

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.41

-0.01

+0.42

Sharpe Ratio (All Time)

Calculated using the full available price history

0.37

0.40

-0.03

Correlation

The correlation between WST and FRT is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

WST vs. FRT - Dividend Comparison

WST's dividend yield for the trailing twelve months is around 0.34%, less than FRT's 4.20% yield.


TTM20252024202320222021202020192018201720162015
WST
West Pharmaceutical Services, Inc.
0.34%0.31%0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%
FRT
Federal Realty Investment Trust
4.20%4.39%2.93%4.21%4.26%3.12%4.96%3.22%3.42%2.98%2.70%2.48%

Drawdowns

WST vs. FRT - Drawdown Comparison

The maximum WST drawdown since its inception was -59.29%, roughly equal to the maximum FRT drawdown of -57.42%. Use the drawdown chart below to compare losses from any high point for WST and FRT.


Loading graphics...

Drawdown Indicators


WSTFRTDifference

Max Drawdown

Largest peak-to-trough decline

-59.29%

-57.42%

-1.87%

Max Drawdown (1Y)

Largest decline over 1 year

-24.70%

-15.66%

-9.04%

Max Drawdown (5Y)

Largest decline over 5 years

-59.29%

-34.99%

-24.30%

Max Drawdown (10Y)

Largest decline over 10 years

-59.29%

-56.47%

-2.82%

Current Drawdown

Current decline from peak

-46.22%

-10.18%

-36.04%

Average Drawdown

Average peak-to-trough decline

-16.79%

-11.81%

-4.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.05%

3.95%

+8.10%

Volatility

WST vs. FRT - Volatility Comparison

West Pharmaceutical Services, Inc. (WST) has a higher volatility of 9.11% compared to Federal Realty Investment Trust (FRT) at 5.37%. This indicates that WST's price experiences larger fluctuations and is considered to be riskier than FRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


WSTFRTDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.11%

5.37%

+3.74%

Volatility (6M)

Calculated over the trailing 6-month period

24.91%

11.89%

+13.02%

Volatility (1Y)

Calculated over the trailing 1-year period

41.43%

21.90%

+19.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.04%

23.45%

+16.59%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.28%

29.41%

+4.87%

Financials

WST vs. FRT - Financials Comparison

This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and Federal Realty Investment Trust. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M700.00M800.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
805.00M
336.05M
(WST) Total Revenue
(FRT) Total Revenue
Values in USD except per share items

WST vs. FRT - Profitability Comparison

The chart below illustrates the profitability comparison between West Pharmaceutical Services, Inc. and Federal Realty Investment Trust over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
37.8%
67.1%
Portfolio components
WST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a gross profit of 303.90M and revenue of 805.00M. Therefore, the gross margin over that period was 37.8%.

FRT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Federal Realty Investment Trust reported a gross profit of 225.48M and revenue of 336.05M. Therefore, the gross margin over that period was 67.1%.

WST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported an operating income of 157.10M and revenue of 805.00M, resulting in an operating margin of 19.5%.

FRT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Federal Realty Investment Trust reported an operating income of 180.65M and revenue of 336.05M, resulting in an operating margin of 53.8%.

WST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a net income of 132.10M and revenue of 805.00M, resulting in a net margin of 16.4%.

FRT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Federal Realty Investment Trust reported a net income of 129.74M and revenue of 336.05M, resulting in a net margin of 38.6%.